-
Intas Pharmaceuticals Ltd
Distance: 1.1 Mi1009 Slater Rd Ste 210B
27703 Durham -
GlaxoSmithKline
Distance: 3.3 Mi5 Moore Drive Research Triangle Park
27709 Durham -
CoLucid Pharmaceuticals, Inc
Distance: 3.0 Mi2530 Meridian Pkwy Ste 300
27713-5273 Durham -
Pharmaceutical Calibrations & Instrumentation, LLC
Distance: 6.4 Mi8100 Brownleigh Dr Ste 100-A
27617 Raleigh -
Synthon Pharmaceuticals Inc
Distance: 8.1 MiPO Box 110487
27709-5487 Durham
Website Links
Description
Endacea, Inc. (RTP, NC), an emerging biopharmaceutical company, is developing a series of proprietary A 1 adenosine receptor (AR) antagonists as drug candidates for a number of medical indications: 1) inflammation, including sepsis and asthma; and 2) renal impairment. Endacea is advancing the Company's lead compound A 1 AR antagonist, L-97-1, as an i.v. anti-sepsis drug candidate and as a post-exposure medical countermeasure for plague and other biodefense indications.